Literature DB >> 9074581

Activation of HHV-8 by HIV-1 tat.

W Harrington, L Sieczkowski, C Sosa, S Chan-a-Sue, J P Cai, L Cabral, C Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9074581     DOI： 10.1016/s0140-6736(05)60199-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  28 in total

1.  Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  V Varthakavi; P J Browning; P Spearman
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.

Authors:  Ossie F Dyson; Christopher M Traylen; Shaw M Akula
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

Review 3.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

4.  The human cytomegalovirus UL112-113 locus can activate the full Kaposi's sarcoma-associated herpesvirus lytic replication cycle.

Authors:  Richard Wells; Laurence Stensland; Jeffrey Vieira
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

5.  FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.

Authors:  Ruoyun Gao; Tingting Li; Brandon Tan; Suzane Ramos da Silva; Jae U Jung; Pinghui Feng; Shou-Jiang Gao
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

6.  Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.

Authors:  J Vieira; P O'Hearn; L Kimball; B Chandran; L Corey
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 7.  A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric Population.

Authors:  Dorothy E Dow; Coleen K Cunningham; Ann M Buchanan
Journal:  J Pediatric Infect Dis Soc       Date:  2013-09-04       Impact factor: 3.164

8.  Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.

Authors:  Qin Yan; Xinting Ma; Chenyou Shen; Xu Cao; Ninghan Feng; Di Qin; Yi Zeng; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice.

Authors:  Xiuying Chen; Lin Cheng; Xuemei Jia; Yi Zeng; Shuihong Yao; Zhigang Lv; Di Qin; Xin Fang; Yongliang Lei; Chun Lu
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

10.  Role of protein kinase C delta in reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Einat Deutsch; Adina Cohen; Gila Kazimirsky; Sara Dovrat; Hadara Rubinfeld; Chaya Brodie; Ronit Sarid
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.